Use of Beta-Blockers in Dogs with Pericardial Effusion and Hemangiosarcoma


To determine whether administration of beta-blockers results in either a prolonged survival or a longer time until recurrence of pericardial effusion in dogs with hemangiosarcoma.

Inclusion Criteria

Dogs with pericardial effusion and a right atrial mass identified on echocardiogram are eligible for the study.

Exclusion Criteria

Dogs with certain severe irregular heart rhythms (e.g., ventricular tachycardia) and dogs who have surgery for the condition.

Client Benefits

The results of this study will help us determine whether treatment with beta-blockers improves the outcome in dogs with this disease. The cost of the recheck echocardiogram is covered by the study.

Contact Information

Dr. John Rush
Phone: (508) 839-5395, ext. 8-4696.